We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

15 hedge funds and large institutions have $710K invested in NeuroMetrix, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

7% more funds holding

Funds holding: 1415 (+1)

35% less capital invested

Capital invested by funds: $1.09M → $710K (-$377K)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q2 2019 in Review

15 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2019, worth a combined $710K — down 35% from $1.09M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NURO positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, adding an estimated $367K. The largest seller was Citadel Advisors, exiting entirely with an estimated $32K sold.

  • 15 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2019, up from 14 in Q1 2019.
  • Funds reported $710K of NeuroMetrix, Inc. Common Stock stock for Q2 2019, down 35% quarter-over-quarter.
  • 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2019 and 2 closed out, a net change of +1 holder.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2019 was Sabby Management, an estimated $367K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q2 2019 was Citadel Advisors, an estimated $32K sold.

Based on aggregated 13F filings for Q2 2019.